Expanded NIH Stem Cell Support Means Novel Drug Development Tools
Executive Summary
A new generation of specialized drug development tools based on human embryonic stem cells - and maybe down the road new regenerative therapies - got a boost with the release of the Obama administration's hESC research guidelines July 6